什麼是 SEC Form 13F 申報?美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制,學會如何追蹤頂級對沖基金與機構法人持倉動向。
CIK: 0001599882
申報總市值
US$10.6億
US$10.6億
95 檔
20.0%
Rhenman & Partners Asset Management AB 在 Q3 2024 季度的美股部位總計估值為 US$10.6億,分散於 95 個持倉標的之中,反映其市場參與廣度與投資規模。
在 Q3 2024 期間,Rhenman & Partners Asset Management AB 展現了靈活的資產再平衡步調,透過出清 6 檔弱勢或達到目標價部位,將資金轉置於 8 檔新建倉標的之中。
從部位權重觀察,前 5 大標的(包含 BSX, UNH, LLY)累計市值佔比達 20.0%,是驅動 Rhenman & Partners Asset Management AB 該季度整體投資組合績效表現的核心支柱。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSX | Boston Scientific CORP | 股票-醫療保健 | 4.01% | -3.03% | -0.84% | |
| 2 | UNH | Unitedhealth Group Inc | 股票-醫療保健 | 3.45% | +2.15% | -30.96% | |
| 3 | LLY | Eli Lilly & Co | 股票-醫療保健 | 3.42% | -1.30% | +1.06% | |
| 4 | REGN | Regeneron Pharmaceuticals | 股票-醫療保健 | 3.33% | -2.98% | +21.88% | |
| 5 | THC | Tenet Healthcare CORP | 股票-醫療保健 | 2.99% | +0.24% | -3.32% | |
| 6 | PRCT | Procept Biorobotics CORP | 股票-其他 | 2.89% | -0.73% | +1.14% | |
| 7 | ABBV | Abbvie Inc | 股票-醫療保健 | 2.84% | +0.38% | -6.35% | |
| 8 | MDT | Medtronic plc | 股票-醫療保健 | 2.69% | +0.11% | +76.92% | |
| 9 | EXK | Exact Sciences CORP | 股票-原物料 | 2.57% | — | +220.69% | |
| 10 | HCA | Hca Healthcare Inc | 股票-醫療保健 | 2.51% | — | -7.04% | |
| 11 | ISRG | Intuitive Surgical Inc | 股票-醫療保健 | 2.51% | -0.80% | +4.13% | |
| 12 | GILD | Gilead Sciences Inc | 股票-醫療保健 | 2.49% | -0.75% | +53.67% | |
| 13 | NTRA | Natera Inc | 股票-醫療保健 | 2.38% | +0.29% | +47.13% | |
| 14 | OSCR | Oscar Health Inc - Class A | 股票-醫療保健 | 2.36% | +0.13% | -28.08% | |
| 15 | MRK | Merck & Co. Inc. | 股票-醫療保健 | 2.22% | +2.59% | NEW | |
| 16 | BDX | Becton Dickinson And Co | 股票-醫療保健 | 2.20% | — | -0.44% | |
| 17 | ELV | Elevance Health Inc | 股票-醫療保健 | 2.13% | +0.10% | -41.14% | |
| 18 | INSP | Inspire Medical Systems Inc | 股票-醫療保健 | 2.09% | — | +617.65% | |
| 19 | BMRN | Biomarin Pharmaceutical Inc | 股票-醫療保健 | 2.08% | +0.13% | +44.93% | |
| 20 | COO | Cooper Cos Inc/the | 股票-醫療保健 | 2.04% | -0.07% | -26.45% | |
| 21 | ALHC | Alignment Healthcare Inc | 股票-其他 | 1.90% | -0.05% | +20.46% | |
| 22 | DHR | Danaher CORP | 股票-醫療保健 | 1.88% | +1.02% | +71.76% | |
| 23 | VRTX | Vertex Pharmaceuticals Inc | 股票-醫療保健 | 1.80% | -0.96% | -11.57% | |
| 24 | RPRX | Royalty Pharma plc | 股票-醫療保健 | 1.41% | -0.34% | +12.63% | |
| 25 | TMO | Thermo Fisher Scientific Inc | 股票-醫療保健 | 1.26% | -1.02% | +4.58% | |
| 26 | ABT | Abbott Laboratories | 股票-醫療保健 | 1.25% | -0.60% | -6.90% | |
| 27 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 1.22% | — | +44.72% | |
| 28 | MCK | Mckesson CORP | 股票-醫療保健 | 1.21% | -0.62% | +0.39% | |
| 29 | GKOS | Glaukos CORP | 股票-醫療保健 | 1.17% | +0.45% | +122.00% | |
| 30 | CI | THE Cigna Group | 股票-醫療保健 | 1.17% | +0.19% | -43.80% | |
| 31 | ALGN | Align Technology Inc | 股票-醫療保健 | 1.14% | +0.84% | -2.65% | |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | 股票-醫療保健 | 1.12% | -0.92% | -41.11% | |
| 33 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.08% | — | -3.44% | |
| 34 | BIIB | Biogen Inc | 股票-醫療保健 | 1.06% | -0.54% | -20.87% | |
| 35 | NVO | Novo-nordisk A/s-spons Adr | 股票-醫療保健 | 0.97% | — | — | |
| 36 | CVS | Cvs Health CORP | 股票-醫療保健 | 0.94% | -0.25% | — | |
| 37 | IQV | Iqvia Holdings Inc | 股票-醫療保健 | 0.92% | -1.12% | EXIT | |
| 38 | AXSM | Axsome Therapeutics Inc | 股票-醫療保健 | 0.89% | +0.13% | -3.92% | |
| 39 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 0.86% | — | +563.42% | |
| 40 | JAZZ | Jazz Pharmaceuticals plc | 股票-醫療保健 | 0.84% | +0.22% | -18.42% | |
| 41 | MOH | Molina Healthcare Inc | 股票-醫療保健 | 0.83% | +0.47% | NEW | |
| 42 | COR | Cencora Inc | 股票-醫療保健 | 0.82% | -0.78% | -12.33% | |
| 43 | IOVA | Iovance Biotherapeutics Inc | 股票-其他 | 0.80% | -0.22% | +14.40% | |
| 44 | HUM | Humana Inc | 股票-醫療保健 | 0.80% | — | — | |
| 45 | CYTK | Cytokinetics Inc | 股票-醫療保健 | 0.77% | — | -8.61% | |
| 46 | INSM | Insmed Inc | 股票-醫療保健 | 0.77% | -1.69% | +30.15% | |
| 47 | PODD | Insulet CORP | 股票-醫療保健 | 0.76% | +0.24% | -13.98% | |
| 48 | NUVL | Nuvalent Inc-a | 股票-其他 | 0.75% | -1.03% | EXIT | |
| 49 | CNC | Centene CORP | 股票-醫療保健 | 0.71% | +1.48% | NEW | |
| 50 | SYK | Stryker CORP | 股票-醫療保健 | 0.67% | -0.01% | +27.78% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | EXK | Exact Sciences CORP | +2% | +220.69% | 加碼 |
| 2 | INSP | Inspire Medical Systems Inc | +1.9% | +617.65% | 加碼 |
| 3 | MDT | Medtronic plc | +1.1% | +76.92% | 加碼 |
| 4 | NVO | Novo-nordisk A/s-spons Adr | +1% | NEW | 新建倉 |
| 5 | CVS | Cvs Health CORP | +0.9% | NEW | 新建倉 |
| 6 | GILD | Gilead Sciences Inc | +0.9% | +53.67% | 加碼 |
| 7 | HUM | Humana Inc | +0.8% | NEW | 新建倉 |
| 8 | NTRA | Natera Inc | +0.8% | +47.13% | 加碼 |
| 9 | DHR | Danaher CORP | +0.7% | +71.76% | 加碼 |
| 10 | ALHC | Alignment Healthcare Inc | +0.7% | +20.46% | 加碼 |
| 11 | APLSUSD | Apellis Pharmaceuticals Inc | +0.7% | +563.42% | 加碼 |
| 12 | MOH | Molina Healthcare Inc | +0.6% | +322.86% | 加碼 |
| 13 | GKOS | Glaukos CORP | +0.6% | +122.00% | 加碼 |
| 14 | EVH | Evolent Health Inc - A | +0.5% | +430.00% | 加碼 |
| 15 | BNTX | Biontech Se-adr | +0.5% | NEW | 新建倉 |
| 16 | TMDX | Transmedics Group Inc | +0.4% | +235.33% | 加碼 |
| 17 | GERN | Geron CORP | +0.4% | NEW | 新建倉 |
| 18 | DNTH | Dianthus Therapeutics Inc | +0.3% | NEW | 新建倉 |
| 19 | PRCT | Procept Biorobotics CORP | +0.3% | +1.14% | 加碼 |
| 20 | ITCIEUR | Intra-cellular Therapies Inc | +0.3% | +44.72% | 加碼 |
| 21 | IQV | Iqvia Holdings Inc | +0.3% | +54.84% | 加碼 |
| 22 | ACHC | Acadia Healthcare Co Inc | +0.3% | +165.54% | 加碼 |
| 23 | IMVT | Immunovant Inc | +0.2% | +86.21% | 加碼 |
| 24 | ACLXGBX | Arcellx Inc | +0.2% | NEW | 新建倉 |
| 25 | BRKR | Bruker CORP | +0.2% | +638.58% | 加碼 |
| 26 | NRIX | Nurix Therapeutics Inc | +0.2% | +72.03% | 加碼 |
| 27 | NUVL | Nuvalent Inc-a | +0.2% | +8.76% | 加碼 |
| 28 | IDYA | Ideaya Biosciences Inc | +0.2% | +138.32% | 加碼 |
| 29 | UHS | Universal Health Services-b | +0.2% | NEW | 新建倉 |
| 30 | MRK | Merck & Co. Inc. | +0.1% | +37.71% | 加碼 |
| 31 | INSM | Insmed Inc | +0.1% | +30.15% | 加碼 |
| 32 | RLAY | Relay Therapeutics Inc | +0.1% | +100.00% | 加碼 |
| 33 | 1K0 | Igm Biosciences Inc | +0.1% | -4.89% | 減碼 |
| 34 | REGN | Regeneron Pharmaceuticals | +0.1% | +21.88% | 加碼 |
| 35 | BBIO | Bridgebio Pharma Inc | +0.1% | +45.26% | 加碼 |
| 36 | MEDP | Medpace Holdings Inc | +0.1% | +200.00% | 加碼 |
| 37 | BMRN | Biomarin Pharmaceutical Inc | +0.1% | +44.93% | 加碼 |
| 38 | IOVA | Iovance Biotherapeutics Inc | +0.1% | +14.40% | 加碼 |
| 39 | SYK | Stryker CORP | +0.1% | +27.78% | 加碼 |
| 40 | THC | Tenet Healthcare CORP | +0.1% | -3.32% | 減碼 |
| 41 | IONS | Ionis Pharmaceuticals Inc | 0% | +50.00% | 加碼 |
| 42 | RPRX | Royalty Pharma plc | 0% | +12.63% | 加碼 |
| 43 | RGEN | Repligen CORP | — | — | 不變 |
| 44 | TMO | Thermo Fisher Scientific Inc | 0% | +4.58% | 加碼 |
| 45 | EHC | Encompass Health CORP | 0% | +1.67% | 加碼 |
| 46 | EPIEUR | Essa Pharma Inc | 0% | -0.17% | 減碼 |
| 47 | TECH | Bio-techne CORP | 0% | — | 不變 |
| 48 | PLRX | Pliant Therapeutics Inc | 0% | — | 不變 |
| 49 | HCA | Hca Healthcare Inc | 0% | -7.04% | 減碼 |
| 50 | XENE | Xenon Pharmaceuticals Inc | 0% | — | 不變 |
根據 SEC 官方 Form 13F 申報備案,Rhenman & Partners Asset Management AB 在 Q3 2024 季度的美股持倉總市值約為 US$10.6億,共申報了 95 個公開持股部位。
在 Q3 2024 季度,Rhenman & Partners Asset Management AB 按市值排列的前三大核心持股分別為:BSX (4.0%)、UNH (3.5%)、LLY (3.4%)。其中最大持股部位 BSX 佔據整體投資組合約 4.0% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析,提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制,學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
NVO
市值: US$1190.7萬
本季最大獲利了結 / 清倉標的
EW
前期市值: US$900.6萬
在 Q3 2024 季度中,Rhenman & Partners Asset Management AB 共進行了 92 項持倉異動,包含新建倉 8 個部位、加碼 39 個部位、減碼 39 個部位以及清倉 6 個部位。 其中最大新建倉標的為 NVO。 本季清倉部位包含 EW。
本頁面所有持股數據均直接同步自美國證券交易委員會(SEC)EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照,提供 100% 精準對齊的歷史時序數據集,並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報,掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異,以及最新 SEC 申報時程規範,洞察機構法人的激進投資動向。